Author: Leung, T. Y. M.; Chan, A. Y. L.; Chan, E. W.; Chan, V. K. Y.; Chui, C. S. L.; Cowling, B. J.; Gao, L.; Ge, M. Q.; Hung, I. F. N.; Ip, M. S. M.; Ip, P.; Lau, K. K.; Lau, C. S.; Lau, L. K. W.; Leung, W. K.; Li, X.; Luo, H.; Man, K. K. C.; Ng, V. W. S.; Siu, C. W.; Wan, E. Y. F.; Wing, Y. K.; Wong, C. S. M.; Wong, K. H. T.; Wong, I. C. K.
Title: Short- and potential long-term adverse health outcomes of COVID-19: a rapid review Cord-id: n1mprcdc Document date: 2020_10_7
ID: n1mprcdc
Snippet: The coronavirus disease 2019 (COVID-19) pandemic has resulted in millions of patients infected worldwide and indirectly affecting even more individuals through disruption of daily living. Long-term adverse outcomes have been reported with similar diseases from other coronaviruses, namely Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). Emerging evidence suggests that COVID-19 adversely affects different systems in the human body. This review summarizes the cu
Document: The coronavirus disease 2019 (COVID-19) pandemic has resulted in millions of patients infected worldwide and indirectly affecting even more individuals through disruption of daily living. Long-term adverse outcomes have been reported with similar diseases from other coronaviruses, namely Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). Emerging evidence suggests that COVID-19 adversely affects different systems in the human body. This review summarizes the current evidence on the short-term adverse health outcomes and assesses the risk of potential long-term adverse outcomes of COVID-19. Major adverse outcomes were found to affect different body systems: immune system (including but not limited to Guillain-Barré syndrome and paediatric inflammatory multisystem syndrome), respiratory system (lung fibrosis and pulmonary thromboembolism), cardiovascular system (cardiomyopathy and coagulopathy), neurological system (sensory dysfunction and stroke), as well as cutaneous and gastrointestinal manifestations, impaired hepatic and renal function. Mental health in patients with COVID-19 was also found to be adversely affected. The burden of caring for COVID-19 survivors is likely to be huge. Therefore, it is important for policy makers to develop comprehensive strategies in providing resources and capacity in the healthcare system. Future epidemiological studies are needed to further investigate the long-term impact on COVID-19 survivors.
Search related documents:
Co phrase search for related documents- acute kidney injury and liver damage: 1, 2, 3, 4, 5, 6
- acute kidney injury and liver dysfunction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- acute kidney injury and liver enzyme: 1, 2, 3
- acute kidney injury and liver injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66
- acute kidney injury and liver involvement: 1, 2, 3, 4
- acute kidney injury and long persist: 1
- acute kidney injury and long term complication: 1
- acute kidney injury and long term effect: 1
- acute kidney injury and long term follow: 1, 2, 3, 4, 5, 6, 7, 8
- acute kidney injury and long term health impact: 1
- acute kidney injury and long term health outcome: 1
- acute kidney injury and long term impact: 1, 2, 3, 4, 5, 6
- acute kidney injury and long term outcome: 1, 2, 3, 4, 5, 6, 7
- acute kidney injury and long term outcome report: 1
- acute kidney injury and long term sequelae: 1, 2, 3, 4
- acute kidney injury and lung damage: 1, 2, 3, 4, 5, 6
- acute kidney injury and lung function: 1, 2, 3, 4, 5, 6, 7, 8
- acute kidney injury and lung parenchymal: 1, 2
- acute kidney injury and lupus erythematosus: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date